Abemaciclib Plus Fulvestrant in Advanced Breast Cancer – OncoDaily
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer / Aarti R. Chawla, Abemaciclib, Bastien Nguyen, Breast Cancer, cancer, Cynthia Sandoval, Dana-Farber’s
Related Articles
Unveiling disparities in cancer care: a comparative study… : Journal of Psychosocial Oncology Research and Practice
ty is often set by health care professionals’ (HCPs’) evaluation about the adequacy of services and programs to meet their patients’ needs. Thus, this study…
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
Expanded Newborn Screening Using Genome Sequencing
This multisite, single-group, prospective, observational study examines the feasibility and potential impact of genomic newborn screening using dried blood spots in a racially and ethnically…
Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma
Studies show promising EFS, PFS, and OS at 3 to 8 years
Regeneratively farmed is the new buzz label on supermarket shelves – but what does it actually mean?
While regenerative agriculture might seem like a pioneering new approach, this term isn’t new. Here’s how it differs from organic.
Andrew Carnegie and the 19th-century ‘robber barons’ have lessons for today’s oligarchs about the responsibilities of wealth
The 19th-century industrialists were called ‘robber barons’ – but they did more to improve society than many of today’s super-rich.
Prognostic models for depression and post-traumatic stress disorder symptoms following traumatic brain injury: a CENTER-TBI study
Background Traumatic brain injury (TBI) is associated with an increased risk of major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). We aimed to identify…
Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma
The epidermal growth factor receptor (EGFR) plays crucial roles in several important biological functions such as embryogenesis, epithelial tissue development, and cellular regeneration. However, in…
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients
Acute myeloid leukemia (AML) has a dismal prognosis, mostly due to minimal residual disease-driven relapse, making an elimination of persisting therapy-resistant leukemia progenitor/stem cells (LPCs)…
Targeting minimal residual disease (MRD) in resected RAS mutated pancreatic cancer with vaccine TG01/QS-21 +/- PD-1 inhibitor, balstilimab: A randomized phase II study (TESLA).
TPS4205 Background: MRD detected by presence of circulating tumor DNA (ctDNA) after intended curative treatment is associated with high risk of relapse in pancreatic cancer.…
